Wieslawa Olszewska - Concepedia

Author

Wieslawa Olszewska

Imperial College London

Also Known As

W OLSZEWSKA, W. Olszewska, Wieslawa Olszewska

Publications

750

Citations

H-Index

Concepts

All Affiliations

Imperial College London University of London London School of Hygiene & Tropical Medicine St Mary's Hospital

About

Wieslawa Olszewska is an author at Imperial College London specializing in vaccination, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	503
2	Immunology	6	6	503
3	Allergy	1	1	213
4	Autoimmunity	1	1	213
5	Immunoengineering	1	1	20

Wieslawa Olszewska

Publications

646

Citations

H-Index

Page 1

	Year	Citations
A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines Amin E. Moghaddam, Wieslawa Olszewska, Belinda Wang, Nature Medicine VaccinationVaccine DevelopmentAllergyVaccine TargetImmunology	2006	213
Immunopathogenesis of vaccine-enhanced RSV disease Peter Openshaw, Fiona J. Culley, Wieslawa Olszewska Vaccine VaccinationVaccine DevelopmentVaccine TargetImmunologyVaccine-enhanced Rsv Disease	2001	171
Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model Wieslawa Olszewska, Gabriela Ispas, Corinna Schnoeller, European Respiratory Journal	2010	55
Protection against Measles Virus-Induced Encephalitis by Anti-mimotope Antibodies: The Role of Antibody Affinity Wieslawa Olszewska, Obeid E. Obeid, Michael Steward Virology VaccinationMedicineVaccine TargetImmunologyVirology	2000	48
Attenuated <i>Bordetella pertussis</i> Vaccine Protects against Respiratory Syncytial Virus Disease via an IL-17–Dependent Mechanism Corinna Schnoeller, X. Roux, Devika Sawant, American Journal of Respiratory and Critical Care Medicine	2013	42
Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins Wieslawa Olszewska, Yasemin Suezer, Gerd Sutter, Vaccine VaccinationVaccinologyMucosal VaccinationVaccine DevelopmentVaccinia Ankara	2004	39
Antipeptide Antibody Responses following Intranasal Immunization: Effectiveness of Mucosal Adjuvants Wieslawa Olszewska, Charalambos D. Partidos, Michael Steward Infection and Immunity	2000	30
Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination Rebecca Helson, Wieslawa Olszewska, Manmohan Singh, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentDna VaccinationMedicine	2008	20
Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis Christina Bartholdy, Wieslawa Olszewska, Anette Stryhn, Journal of General Virology	2004	16
Immune responses and protection induced by mucosal and systemic immunisation with recombinant measles nucleoprotein in a mouse model of measles virus-induced encephalitis Wieslawa Olszewska, Joseph Erume, J. Ripley, Archives of Virology VaccinationMucosal VaccinationVaccine DevelopmentViral PathogenesisImmunology	2001	12

Page 1